Monitor the PTAB trial schedule and any related district-court or ITC litigation that may be stayed pending the PGR outcome. The patent's subject matter (physical unclonable functions) suggests hardware/security relevance, but the decision provides no detail on Okta's exposure.
Price Chart
Executive Summary
The USPTO PTAB granted institution of post-grant review (PGR2026-00045) on a patent titled 'METHOD OF IMPLEMENTING A PHYSICAL UNCLONABLE FUNCTION' at the petition of Okta, Inc. and Okta GmbH. This is an interlocutory decision — no claims have been cancelled — and the trial will proceed on the merits. For Okta as petitioner, a successful outcome could remove a potential patent obstacle, but the proceeding is early-stage and the patent's link to any Okta product or revenue is not stated in the decision.
PTAB Trial Details
Key Facts
- Okta, Inc. and Okta GmbH are the petitioners in PGR2026-00045.
- The Board granted institution, finding a reasonable likelihood that at least one challenged claim is unpatentable.
- The patent at issue is U.S. 12395359, titled 'METHOD OF IMPLEMENTING A PHYSICAL UNCLONABLE FUNCTION'.
- This is an interlocutory ruling — no claims have been cancelled; a final written decision is expected within approximately one year.
- The decision does not name any specific Okta product or revenue line tied to the patent.
Financial Impact
Not quantifiable from the decision — no damages, revenue exposure, or product link is stated.
Risk Factors
- If the patent owner prevails at final written decision, the patent claims survive and Okta's petition fails.
- The decision does not disclose related litigation or products at stake, making materiality uncertain.
- Appeal to the Federal Circuit is possible after a final written decision, extending the timeline.
Investment Themes
Documents Analyzed
This report is based on 1 PTAB decision.
| Document | Accession Number |
|---|---|
| PTAB-TRIAL Data (Synthetic) | ptab-PGR2026-00045-ins-OKTA |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Institutional Cluster | $208.64 | awaiting T+20 | — | $220.01 (+5.45%) |
Oct 19, 2026 8d ago | PTAB Trial | $194.02 | awaiting T+20 | — | $220.01 (+13.40%) |
Oct 7, 2026 19d ago | 144 | $220.21 | awaiting T+20 | — | $220.01 (−0.09%) |
Sep 24, 2026 4w ago | Insider Cluster | $195.19 $213.05 | ▲ +9.15% | ▲ +10.63% | $220.01 (+12.72%) |
Sep 18, 2026 5w ago | 8-K | $191.33 $189.93 | ▼ −0.73% | ▲ +0.18% | $220.01 (+14.99%) |
Jun 23, 2026 17w ago | 8-K | $118.58 $136.69 | ▲ +15.27% | ▲ +13.34% | $220.01 (+85.54%) |
May 28, 2026 21w ago | 8-K | $123.27 $131.31 | ▲ +6.52% | ▲ +8.32% | $220.01 (+78.48%) |
May 7, 2026 24w ago | DEFA14A | $83.85 $118.72 | ▲ +41.58% | ▲ +41.56% | $220.01 (+162.38%) |
Mar 23, 2026 31w ago | 8-K | $80.69 $77.28 | ▼ −4.23% | ▼ −11.65% | $220.01 (+172.65%) |
Mar 19, 2026 31w ago | Insider Cluster | $80.71 $72.05 | ▼ −10.73% | ▼ −18.35% | $220.01 (+172.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time PTAB Decision Intelligence
Market-moving PTAB patent decisions analyzed within minutes. Trial institutions, denials, final written decisions, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers